Foghorn Therapeutics Inc Financial Flexibility Index
Foghorn Therapeutics Inc financial flexibility index. Foghorn Therapeutics Inc (FHTX) has a Financial Flexibility Index of -0.07x as of June 2026. Free cash flow of $-18.85 Million (operating CF $-18.90 Million minus capex $50.00K) represents 0% of total liabilities ($284.43 Million). See Foghorn Therapeutics Inc (FHTX) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Foghorn Therapeutics Inc (2018–2025)
Financial flexibility index of Foghorn Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Foghorn Therapeutics Inc across 8 annual periods. Explore how well can Foghorn Therapeutics Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Foghorn Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
Foghorn Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Foghorn Therapeutics Inc. For the full cash flow conversion analysis, see FHTX cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-86.05 Million | $-86.10 Million | $306.60 Million | ▲ +7.1% |
| 2024 | -0.30x | $-99.50 Million | $-100.41 Million | $329.51 Million | ▲ +6.2% |
| 2023 | -0.32x | $-116.88 Million | $-118.11 Million | $363.11 Million | ▼ -166.9% |
| 2022 | 0.48x | $194.82 Million | $193.61 Million | $404.77 Million | ▲ +533.7% |
| 2021 | -0.11x | $-46.94 Million | $-50.25 Million | $422.90 Million | ▲ +19.6% |
| 2020 | -0.14x | $-15.10 Million | $-31.29 Million | $109.41 Million | ▲ +66.4% |
| 2019 | -0.41x | $-45.37 Million | $-46.34 Million | $110.36 Million | ▼ -60.4% |
| 2018 | -0.26x | $-21.11 Million | $-22.65 Million | $82.33 Million | — |